Weili Fu

Title: Weili Fu: Innovator in Biomedical Technology

Introduction

Weili Fu is a prominent inventor based in Chengdu, China. He has made significant contributions to the field of biomedical technology, particularly through his innovative research and development of novel materials.

Latest Patents

Weili Fu holds a patent for a "Leonurine nanocomposite hydrogel and preparation methods and applications thereof." This patent focuses on a groundbreaking approach to creating a leonurine nanocomposite hydrogel. The process involves dissolving dopamine (DA) monomers, inducing oxidation and self-polymerization to obtain polydopamine (PDA) nanoparticles, and grafting thiol polyethylene glycol folic acid (SH-PEG-FA) onto the surface of these nanoparticles. The resulting folic acid polydopamine (FA-PDA) nanocarriers are then used to load leonurine (Leon) and encapsulate it into a gel matrix, resulting in the gel@FA-PDA@Leon hydrogel.

Career Highlights

Weili Fu is affiliated with Sichuan University, where he continues to advance his research in biomedical applications. His work has garnered attention for its potential impact on medical treatments and drug delivery systems.

Collaborations

Weili Fu collaborates with notable colleagues, including Runze Yang and Liwei Yan, who contribute to his research endeavors.

Conclusion

Weili Fu's innovative work in developing the leonurine nanocomposite hydrogel exemplifies the potential of biomedical technology to transform healthcare solutions. His contributions are paving the way for future advancements in the field.